Iridian Asset Management LLC CT Cuts Stake in Stericycle, Inc. (NASDAQ:SRCL)

Iridian Asset Management LLC CT lowered its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 18.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 177,522 shares of the business services provider's stock after selling 38,959 shares during the quarter. Stericycle makes up 1.6% of Iridian Asset Management LLC CT's holdings, making the stock its 14th largest position. Iridian Asset Management LLC CT owned about 0.19% of Stericycle worth $8,798,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Impax Asset Management Group plc lifted its holdings in Stericycle by 4.9% during the fourth quarter. Impax Asset Management Group plc now owns 3,139,032 shares of the business services provider's stock valued at $154,396,000 after purchasing an additional 147,452 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Stericycle by 28.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 450,000 shares of the business services provider's stock valued at $22,302,000 after buying an additional 99,617 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in Stericycle by 4,856.0% in the 4th quarter. International Assets Investment Management LLC now owns 38,062 shares of the business services provider's stock worth $1,886,000 after buying an additional 37,294 shares during the last quarter. Strategic Blueprint LLC increased its stake in Stericycle by 6.2% during the 4th quarter. Strategic Blueprint LLC now owns 5,609 shares of the business services provider's stock worth $278,000 after buying an additional 326 shares in the last quarter. Finally, Equitable Trust Co. lifted its position in shares of Stericycle by 7.1% in the fourth quarter. Equitable Trust Co. now owns 7,120 shares of the business services provider's stock valued at $353,000 after acquiring an additional 473 shares in the last quarter. 98.82% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently commented on SRCL. Royal Bank of Canada reiterated an "outperform" rating and set a $69.00 price target on shares of Stericycle in a research report on Thursday, March 7th. StockNews.com downgraded shares of Stericycle from a "buy" rating to a "hold" rating in a research note on Tuesday, April 2nd. Wells Fargo & Company upped their price objective on shares of Stericycle from $40.00 to $48.00 and gave the company an "underweight" rating in a research note on Friday, March 1st. Truist Financial increased their price objective on shares of Stericycle from $50.00 to $57.00 and gave the company a "hold" rating in a report on Thursday, February 29th. Finally, Stifel Nicolaus boosted their target price on Stericycle from $70.00 to $75.00 and gave the stock a "buy" rating in a report on Thursday, February 29th. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $62.25.

Stericycle Trading Down 1.4 %

Shares of SRCL stock traded down $0.72 on Friday, hitting $49.26. 277,614 shares of the stock traded hands, compared to its average volume of 452,495. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94. The firm's 50-day moving average price is $51.32 and its two-hundred day moving average price is $47.81. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $57.06. The stock has a market capitalization of $4.57 billion, a PE ratio of -205.24, a PEG ratio of 2.71 and a beta of 1.09.

Stericycle (NASDAQ:SRCL - Get Free Report) last released its quarterly earnings results on Wednesday, February 28th. The business services provider reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. The firm had revenue of $652.00 million for the quarter, compared to analyst estimates of $657.99 million. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The business's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.60 EPS. As a group, analysts anticipate that Stericycle, Inc. will post 2.31 EPS for the current year.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.